Home › NDC Lookup › RxCUI directory › RxCUI 1656650

Basiliximab 20 MG Injection [Simulect] — RxCUI 1656650

Name: Basiliximab 20 MG Injection [Simulect] (RxCUI 1656650)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1656650 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1656650

Official nameBasiliximab 20 MG Injection [Simulect]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asSimulect 20 MG Injection

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Basiliximab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It does seem surprising, but Simulect is designed to work that way. Just two IV doses — one before your surgery and one four days later — are enough to block the specific immune si...
Why do I only get two doses of this medicine? That seems like very little.
The most important thing to watch for is a severe allergic reaction, which can happen within 24 hours of the dose. Signs include sudden trouble breathing, wheezing, a rapid heartbe...
What should I watch for after getting Simulect?

📖 Read our full Basiliximab Injection guide →

🕸️ Concept Web — How Basiliximab 20 MG Injection [Simulect] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Basiliximab 20 MG Injection [Simulect] RxCUI 1656650 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Basiliximab 196102 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Simulect 219912 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Basiliximab Injection 1656642 SCDF
- Basiliximab Injectable Product 1159396 SCDG
- Basiliximab Injection [Simulect] 1656645 SBDF
- Simulect Injectable Product 1182652 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Basiliximab 20 MG Injection 1656648 SCD
- Basiliximab 20 MG 1656647 SCDC
- Basiliximab 20 MG [Simulect] 1656649 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Basiliximab 20 MG Injection SCD · 1656648
Basiliximab 20 MG SCDC · 1656647
Basiliximab Injection SCDF · 1656642
Basiliximab Injectable Product SCDG · 1159396

Brand-Name Concepts

Basiliximab 20 MG [Simulect] SBDC · 1656649
Basiliximab Injection [Simulect] SBDF · 1656645
Simulect Injectable Product SBDG · 1182652
Simulect BN · 219912

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1656650 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00078-0331-84	1 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 V...	Simulect	Novartis Pharmaceuticals Corporation	1998-05-12
00078-0393-61	1 VIAL, SINGLE-USE in 1 CARTON (0078-0393-61) / 2.5 mL in 1...	Simulect	Novartis Pharmaceuticals Corporation	1998-05-12

Observed labelers: Novartis Pharmaceuticals Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0480	Basiliximab	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.